FDA 483 - Shriram Institute for Industrial Research - February 29, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected Shriram Institute for Industrial Research in Delhi, India, a control testing laboratory, and issued a Form 483. The inspection revealed significant deficiencies including inadequate quality control unit procedures, unreliable electronic records and laboratory instrument validation, unverified testing methods, insufficient investigation of discrepancies, and a lack of cGMP/GLP training for employees. These issues indicate a systemic failure to adhere to good manufacturing and laboratory practices.
ID · 0d11146c-f589-4f38-a4a2-180de5414188